𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: Back to basics

✍ Scribed by Scott Kellerman; Miriam J. Alter

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
31 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of hepatitis B, hepatitis C,
Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam
✍ Kakumu, Shinichi; Sato, Katsuhiko; Morishita, Takayuki; Anh, Trinh Kim; Binh, Ng πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

The prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and GB virus C or hepatitis G virus (GBV-C/HGV) infections was determined in 289 patients with liver disease in Ho Chi Minh City and 890 healthy inhabitants of its rural area, Dalat City, Vietnam, respectively. Serum HCV RNA and GBV

Low HBV-DNA levels in end-stage renal di
Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B
✍ Renata S. Moutinho; Renata M. Perez; JosΓ© O. Medina-Pestana; Mauro S. Figueiredo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

## Abstract In end‐stage renal disease patients treated by hemodialysis with HBeAg‐negative chronic hepatitis B virus (HBV) infection, the evaluation of the presence of viral replication is essential in the assessment for renal transplantation. Data on HBV viral load, prevalence of precore mutation

T- and B-cell responses to different hep
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti- hepatitis C virusβ€”positive blood donors without viremi
✍ M Lechmann; H G Ihlenfeldt; I Braunschweiger; G Giers; G Jung; B Matz; R Kaiser; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 244 KB πŸ‘ 2 views

Β¨b-37 months [range, 28 months-23 years] as documented by the first ingen, Tu Β¨bingen, Germany.

Response to long-term lamivudine treatme
Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C
✍ Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Yoshiyuki Suzuki; Yasuji Arase; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 2 views

## Abstract Response to lamivudine treatment longer than 1 year was compared in 15 patients persistently infected with hepatitis B virus (HBV) genotype A, 38 with genotype B, and 449 with genotype C. Patients with genotype A were younger (median age 37 [range 24–49] vs. 47 [24–67] or 44 [18–73], __